Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€36.25
28.11.21
€39.00
28.02.22
9.79%
28.02.22

Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Encavis AG

Start price
Target price
Perf. (%)
€16.37
28.11.21
€18.20
28.11.22
-6.84%
12.12.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€2.64
28.11.21
-
28.11.22
-77.46%
29.11.22

Risky Investment
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.24
27.11.21
€8.00
27.11.22
-47.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.41
27.11.21
€0.60
27.11.22
-56.65%
28.11.22

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.31
27.11.21
-
27.11.22
11.62%
12.12.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€264.10
27.11.21
€300.00
31.12.23
-46.31%
08.05.23

Could be worthwhile Investment >10% per year
buy
Peloton Interactive Inc.

Start price
Target price
Perf. (%)
€41.75
27.11.21
€60.00
31.12.23
-77.35%
25.07.22

Could be worthwhile Investment >10% per year
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€75.50
27.11.21
€100.00
31.12.23
-5.30%
08.05.23

Could be worthwhile Investment >10% per year
buy
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€201.45
27.11.21
€230.00
31.12.23
-71.40%
08.05.23

Could be worthwhile Investment >10% per year
Boeing Co.

Start price
Target price
Perf. (%)
€175.50
27.11.21
€150.00
31.12.23
-25.44%
28.06.22

Could be worthwhile Investment >10% per year
Boeing Co.

Start price
Target price
Perf. (%)
€175.50
27.11.21
€150.00
31.12.23
-25.44%
28.06.22

Could be worthwhile Investment >10% per year
buy
Encavis AG

Start price
Target price
Perf. (%)
€16.37
27.11.21
-
27.11.22
18.51%
28.11.22

Revenue growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
negative Cash Flow expected
buy
Energiekontor

Start price
Target price
Perf. (%)
€75.50
27.11.21
-
27.11.22
17.22%
28.11.22

EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Good rating
buy
STO SE & Co. KGaA

Start price
Target price
Perf. (%)
€201.00
27.11.21
-
27.11.22
-23.18%
28.11.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Tesla Inc

Start price
Target price
Perf. (%)
€322.03
27.11.21
€206.67
27.11.22
-17.50%
21.07.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High valuation
Tesla Inc

Start price
Target price
Perf. (%)
€322.03
27.11.21
€206.67
27.11.22
-17.50%
21.07.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High valuation
Zynga Inc.

Start price
Target price
Perf. (%)
€5.74
27.11.21
€4.80
27.11.22
39.69%
14.03.22

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€59.95
27.11.21
€75.00
27.11.22
-29.44%
28.11.22

Could be very worthwhile Investment >20% year
Few uniques
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
K+S AG

Start price
Target price
Perf. (%)
€14.65
27.11.21
-
27.11.22
49.47%
16.11.22